contrast, marked differences were found in this value between skin tissue samples from different species. The Mr of lysyl oxidase in crude extracts of human skin and in the medium of cultured human skin fibroblasts was 30000 by gel filtration, no active species with a higher Mr being detectable. Four forms of lysyl oxidase activity were seen in DEAE-cellulose chromatography of urea extract from human skin, all having M, 30000. Antibodies to human placental lysyl oxidase stained a 30000-Mr protein in urea extracts of all the human tissues studied and in the medium of cultured human skin fibroblasts when examined by immunoblotting after sodium dodecyl sulphate/ polyacrylamide-slab-gel electrophoresis, but they also stained high-Mr material. The findings suggest that there are no immunologically distinct lysyl oxidase isoenzymes in the various human tissues and that the true Mr of lysyl oxidase in crude urea extracts is 30000.
Lysyl oxidase (protein-lysine 6-oxidase, EC 1.4.3.13) is a copper enzyme that initiates the crosslinking of collagens and elastin by converting the amine side chains of specific lysine and hydroxylysine residues into aldehydes (see Siegel, 1979) . The enzyme has been purified to near-homogeneity or homogeneity from several animal sources (see Siegel, 1979; Sullivan & Kagan, 1982) and human placental tissue (Kuivaniemi et al., 1984) , and two specific antisera have been prepared to the human placental enzyme (Kuivaniemi et al., 1984) .
The Mr of lysyl oxidase has been reported to be about 30000 or 60000, but values of 80000 and 160000 have also been obtained, different M, values having even been recorded for enzyme from the same sources (see Siegel, 1979) . Preparations of lysyl oxidase from all the sources studied are heterogeneous, with multiple peaks of activity in DEAE-cellulose chromatography. The reasons for this are unknown, but investigations have indicated that there are no definite structural, catalytic or immunological differences between the various forms (Sullivan & Kagan, 1982; Kuivaniemi et al., 1984) .
One possible explanation for the conflicting data concerning the molecular properties of lysyl oxidase is that tissues may contain several isoenzymes and that the purification procedures used may have selected one or other of these. The present work set out, therefore, to study the enzyme in crude tissue extracts. Special emphasis was laid upon the following questions. Are there distinct differences between the lysyl oxidase found in different human tissues or in different species when determined by inhibition studies with antibodies to human placental lysyl oxidase? What is the Mr of lysyl oxidase in crude extracts from various human tissues? Is lysyl oxidase heterogeneous when studied by DEAE-cellulose chromatography of crude human skin extract?
Experimental Materials
The substrate of [6-3H] lysine-labelled purified chick-embryo calvaria collagen and a collagenagarose affinity column were prepared as described previously (Kuivaniemi et al., 1984) . Two specific antisera to human placental lysyl oxidase were available, one to total enzyme protein (antiserum T) and the other to lysyl oxidase purified from the DEAE-cellulose chromatography peaks 1 and 2 (antiserum I) (Kuivaniemi et al., 1984) . Both were immunoadsorbed on a Vol. 230 column containing a purified lysyl oxidase contaminant linked to agarose (Kuivaniemi et al., 1984) . The sources of the other materials were as described elsewhere (Peltonen et al., 1983; Kuivaniemi et al., 1984) .
The human tissue pieces were obtained from those removed in various surgical operations, all the tissues being thus removed from the patients on medical indications. The placentas were obtained from normal deliveries and caesarian sections.
Preparation of tissue extracts and cell-culture media
The human tissue pieces were freshly minced with scissors and homogenized in 0.15M-NaCl/O. 1 M-sodium phosphate buffer, pH 7.8 (10 ml/g of tissue) in an Ultra-Turrax homogenizer four times for 5s at 0°C. The homogenate was centrifuged at 15000g for 30min at 4°C. The supernatant, which did not contain any lysyl oxidase activity, was discarded, and the pellet was suspended in 6M-urea in 10mM-sodium phosphate buffer, pH 7.8 (2ml/g of tissue), stirred overnight at 4°C and centrifuged as above. The supernatant was used for the lysyl oxidase assay.
The human placental enzyme was prepared as described elsewhere (Kuivaniemi et al., 1984) . Because of the very low activity of lysyl oxidase in the urea extract of placenta, the placental enzyme used in activity assays with antiserum was purified by collagen-agarose chromatography and that used in immunoblotting by collagen-agarose and DEAE-cellulose chromatographies, all of these being performed as described previously (Kuivaniemi et al., 1984) .
Skin from a 6-month-old rabbit, a 5-month-old guinea pig, a 60-day-old rat, a 90-day-old mouse and 16-day chick embryos was homogenized as above, except that lOml of 6M-urea/phosphate buffer was used per g of tissue.
Fibroblast cultures were established from human skin specimens, mouse 3T3 skin fibroblasts and smooth-muscle cells of bovine aorta. The cells were grown as described elsewhere (Peltonen et al., 1983) , and samples of the culture media were used to assay the lysyl oxidase activity (Peltonen et al., 1983) . DEAE-cellulose and Sephacryl S-200 chromatographies of human tysyl oxidase A sample of the urea extract from human skin was applied to a 60-ml DEAE-cellulose column equilibrated with 6M-urea in 10mM-sodium phosphate buffer, pH7.8, at 4°C. The column was washed with 60ml of the equilibration buffer and eluted with an 80ml linear gradient of 0-0.5M-NaCl in the 6M-urea/phosphate buffer. Sephacryl S-200 chromatography was performed by applying a sample of the urea extract of human skin or (NH4)2S04-precipitated culture medium of human skin fibroblasts to a column (1.5cm x 90cm) equilibrated and eluted with 6M-urea buffered as above. Other methods Lysyl oxidase activity was assayed as described previously (Peltonen et al., 1983; Kuivaniemi et al., 1984) .
Sodium dodecyl sulphate/polyacrylamide-slabgel electrophoresis was performed with 12%-acrylamide gels (King & Laemmli, 1971) , and immunoblotting experiments after electrophoresis were performed as described previously (Kuivaniemi et al.,1984) . The lysyl oxidase activity in human tissues was expressed per mg of tissue protein assayed by the oa-amino N method of Rubinstein & Pryce (1959) . Tissue pieces (about 50mg) were hydrolysed in 2ml of 6M-HCI at 1 20°C for 20h, and the a-amino N content was determined in the hydrolysates. The protein content of the fractions in the various chromatographies was measured by determining A280 or A230, with bovine serum albumin as the standard.
Results and discussion
Comparison of the amounts of tysyl oxidase activity in the human tissues Human venous, cartilage, fascia, skin, pleura, lung and placental tissues were chosen for study here because they altogether contain collagen types I-VII (Bornstein & Sage, 1980; Bentz et al., 1983; Hessle & Engvall, 1984) The immunological studies were performed with antisera to the human placental enzyme, the only lysyl oxidase that had been purified from any human tissue (Kuivaniemi et al., 1984) . Two specific antisera were available, antiserum T (prepared to total lysyl oxidase protein) being more effective in inhibiting the native enzyme, and antiserum I (prepared to the enzyme purified from DEAE-cellulose chromatography peaks 1 and 2) being more effective in staining the denatured enzyme protein (Kuivaniemi et al., 1984) .
The human venous, cartilage, fascia, skin and placental lysyl oxidases were compared with respect to their inhibition by antiserum T. This antiserum completely inhibited the activity of crude lysyl oxidase from all these tissues. The inhibition curves were mutually similar (as shown for the skin, venous and cartilage enzymes in Fig.  la) . Similarly, no significant differences were found between the tissues in the amounts of antiserum required for 50% inhibition of lOOOd.p.m. of lysyl oxidase activity (Table 1) . In order to determine whether the antibody inhibition approach used above could reveal any differences in cases of lysyl oxidases that are likely to be only slightly different, this same technique was used to study the immunological characteristics of lysyl oxidases from several animal sources. A considerable degree of species specificity was found, as the inhibition curves obtained were distinctly different from those of the human enzymes (as shown for the mouse and rat skin enzymes compared with the human skin enzyme in Fig. lb) . The highest degree of inhibition obtained was in most cases only about 40-50%, and the amount of antiserum required for 40% inhibition of lOOOd.p.m. of enzyme activity was 4-8-fold higher with animal than with human enzymes (Table 2) .
Human and animal lysyl oxidases have previously been reported to be very similar with respect to a number of molecular and catalytic properties (Stassen, 1976; Siegel, 1979; Vol. 230
1982; Kuivaniemi et al., 1984) . The inhibition assay used in the present study thus seems to be able to detect differences between enzymes that are only slightly different. The failure to find any such differences between the lysyl oxidases in crude extracts from various human tissues therefore suggests that lysyl oxidase may nrvt have any tissue-specific isoenzymes. The absence of immunologically distinct lysyl oxidase isoenzymes suggests that antisera prepared against placental lysyl oxidase can also be used to study the enzyme in other human tissues. It would thus seem possible to use these antibodies to develop a radioimmunoassay for the enzyme protein. Such a method might also provide an opportunity to assay lysyl oxidase from serum samples, which has so far been difficult owing to the presence of inhibitors of the enzyme activity (Shieh et al., 1977) .
Molecular properties of crude lysyl oxidase from several human tissues Sephacryl S-200 gel filtration of the crude skin and skin-fibroblast-medium lysyl oxidases, carried out in 6M-urea, gave only a single peak of activity, the elution position of which corresponded to an Mr of about 30000 (result not shown). Immunoblotting performed with antiserum I after sodium dodecyl sulphate/polyacryl-amide-slab-gel electrophoresis likewise demonstrated the presence of a 30000-Mr protein in the urea extracts from all the tissues studied (as shown for cartilage, fascia and skin in Fig. 2 ) and in the medium of cultured skin fibroblasts (Fig. 2, lanes (results not shown) and that a minor part of pure human lysyl oxidase may polymerize to a 60 000-Mr form during sodium dodecyl sulphate/polyacrylamide-gel electrophoresis (Kuivaniemi et al., 1984) . As no enzyme activity corresponding to such polymers was found in gel filtration, and as the high-M, material did not block the antiserum from inhibiting the enzyme activity (results not shown), the polymerization may occur in such a way that the active site becomes hidden inside the polymers.
When the crude urea extract of human skin was studied by DEAE-cellulose chromatography, four peaks of lysyl oxidase activity were found, all having the same Mr, 30000, as determined by immunoblotting after sodium dodecyl sulphate/ polyacrylamide-slab-gel electrophoresis (results not shown). As the four enzyme forms were found here to be present even in crude tissue extracts, and as their presence is unaffected by the use of several proteinase inhibitors (Kagan et al., 1979) , these forms are not likely to be due to any artifacts. The differences may exist at the level of some posttranslational modification of the enzyme protein, but the possibility is not excluded that the multiple forms may represent products of four very similar but not identical genes that are expressed in a number of tissues.
